User menu

A MAGE-3 peptide presented by HLA-B44 is also recognized by cytolytic T lymphocytes on HLA-B18

Bibliographic reference Bilsborough, Janine ; Panichelli, C ; Duffour, MT ; Warnier, G. ; Lurquin, C. ; et. al. A MAGE-3 peptide presented by HLA-B44 is also recognized by cytolytic T lymphocytes on HLA-B18. In: Tissue Antigens, Vol. 60, no. 1, p. 16-24 (2002)
Permanent URL
  1. Gaugler B., Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes, 10.1084/jem.179.3.921
  2. De Plaen E, Immunogenetics, 40, 360 (1994)
  3. Lurquin Christophe, De Smet Charles, Brasseur Francis, Muscatelli Françoise, Martelange Valérie, De Plaen Etienne, Brasseur Robert, Monaco Anthony P., Boon Thierry, Two Members of the HumanMAGEBGene Family Located in Xp21.3 Are Expressed in Tumors of Various Histological Origins, 10.1006/geno.1997.5052
  4. Lucas S, Cancer Res, 58, 743 (1998)
  5. Chomez P, Cancer Res, 61, 5544 (2001)
  6. Boon T, Principles and Practice of the Biologic Therapy of Cancer, 493 (2000)
  7. Tanzarella S, Cancer Res, 59, 2668 (1999)
  8. Kawashima Ichiro, Hudson Stephen J, Tsai Van, Southwood Scott, Takesako Kazutoh, Appella Ettore, Sette Alessandro, Celis Esteban, The Multi-epitope Approach for Immunotherapy for Cancer: Identification of Several CTL Epitopes from Various Tumor-Associated Antigens Expressed on Solid Epithelial Tumors, 10.1016/s0198-8859(97)00255-3
  9. Tanaka F, Cancer Res, 57, 4465 (1997)
  10. Herman Jean, van der Bruggen P., Luescher Immanuel F., Mandruzzato Susanna, Romero Pedro, Thonnard Joëlle, Fleischhauer Katharina, Boon Thierry, Coulie P. G., A peptide encoded by the human MAGE3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3 , 10.1007/s002510050078
  11. Schultz E.S., Zhang Y., Knowles R., Tine J., Traversari C., Boon T., van der Bruggen P., A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytes, 10.1034/j.1399-0039.2001.057002103.x
  12. Graham FL, J General Virol, 36, 59 (1977)
  13. Parham P, J Immunol, 123, 342 (1979)
  14. Van Snick J, J Exp Med, 165, 641 (1987)
  15. Shimizu Y, J Immunol, 142, 3320 (1989)
  16. Rebai N, Tissue Antigens, 22, 107 (1983)
  17. Stratford-Perricaudet LD, J Clin Invest, 90, 626 (1992)
  18. Riviere I, Proc Natl Acad Sci U S A, 92, 6733 (1995)
  19. Chaux Pascal, Vantomme Valérie, Stroobant Vincent, Thielemans Kris, Corthals Jurgen, Luiten Rosalie, Eggermont Alexander M.M., Boon Thierry, van der Bruggen Pierre, Identification of MAGE-3 Epitopes Presented by HLA-DR Molecules to CD4+T Lymphocytes, 10.1084/jem.189.5.767
  20. Sory MP, Mol Microbiol, 14, 583 (1994)
  21. Cornelis GR, J Bacteriol, 180, 5495 (1998)
  22. Boland A, Infect Immun, 66, 1878 (1998)
  23. Neyt C, J Bacteriol, 179, 612 (1997)
  24. Traversari C, Immunogenetics, 35, 145 (1992)
  25. Beyaert R, Proc Natl Acad Sci U S A, 86, 9494 (1989)
  26. Espevik Terje, Nissen-Meyer Jon, A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes, 10.1016/0022-1759(86)90322-4
  27. Traversari C, J Exp Med, 176, 1453 (1992)
  28. van der Bruggen P, Eur J Immunol, 24, 2134 (1994)
  29. Chaux P, J Immunol, 163, 2928 (1999)
  30. Luiten R., van der Bruggen P., A MAGE-A1 peptide is recognized on HLA-B7 human tumors by cytolytic T lymphocytes, 10.1034/j.1399-0039.2000.550206.x
  31. Garrido F, Adv Cancer Res, 67, 155 (1995)
  32. Ferrone Soldano, Marincola Francesco M., Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinial relevance, 10.1016/0167-5699(95)80033-6
  33. Herman J, Tissue Antigens, 53, 111 (1999)
  34. Tussey LG, Immunity, 3, 65 (1995)
  35. Marsh SGE, The HLA Factsbook. (2000)
  36. Voorter C.E.M., van der Vlies S., Kik M., van den Berg-Loonen E.M., Unexpected Bw4 and Bw6 reactivity patterns in new alleles, 10.1034/j.1399-0039.2000.560409.x
  37. Bourgault Villada Isabelle, Bénéton Nathalie, Bony Claire, Connan Francine, Monsonego Jean, Bianchi Anne, Saiag Philippe, Lévy Jean Paul, Guillet Jean Gérard, Choppin Jeannine, Identification in humans of HPV-16 E6 and E7 protein epitopes recognized by cytolytic T lymphocytes in association with HLA-B18 and determination of the HLA-B18-specific binding motif, 10.1002/1521-4141(2000)30:8<2281::aid-immu2281>;2-n
  38. Luiten R.M., Demotte N., Tine J., van der Bruggen P., A MAGE-A1 peptide presented to cytolytic T lymphocytes by both HLA-B35 and HLA-A1 molecules, 10.1034/j.1399-0039.2000.560110.x
  39. 40. B Van den Eynde, and P van der Bruggen . Peptide database of T-cell defined tumor antigens . Cancer Immunity2001 :